Trajectories of Depressive Symptoms in Older Adults and Associated Health Outcomes
Mousavi, S. et al. Depression, chronic diseases and deterioration of health: results from world health surveys. Lancet 370851–858 (2007).
Wei, J. et al. The association of late-onset depression with all-cause and cardiovascular mortality in community-dwelling older adults: a systematic review and meta-analysis. Br. J. Psychiatry 215449–455 (2019).
Alexopoulos, GS Mechanisms and treatment of depression at the end of life. Transl. Psychiatry 9188 (2019).
However, SM, et al. Comorbid depression in medical illnesses. Nat. Rev. Say. Primers 669 (2020).
Menear, M. et al. The influence of comorbid chronic physical conditions on the recognition of depression in primary care: a systematic review. J. Psychosom. Res. 78304-313 (2015).
Unützer, J. et al. Collaborative management of late depression care in primary care: a randomized controlled trial. Jam. Med. Assoc. 2882836–2845 (2002).
Kuchibhatla, MN, Fillenbaum, GG, Hybels, CF & Blazer, DG Trajectory classes of depressive symptoms in a community sample of older adults. Acta Psychiatrist. Scan. 125492-501 (2012).
Mirza, SS et al. 10-year trajectories of depressive symptoms and dementia risk: a population-based study. Lancet Psychiatry 3628–635 (2016).
Saeed Mirza, S. et al. 12-year trajectories of depressive symptoms in community-dwelling older adults and subsequent 13-year risk of death. J. Gerontol. A Biol. Science. Med. Science. 73820–827 (2018).
Formánek, T. et al. Trajectories of depressive symptoms and associated patterns of cognitive decline. Science. Representing. ten20888 (2020).
Sutin, AR et al. The trajectory of depressive symptoms throughout adult life. JAMA Psychiatry 70803–811 (2013).
Da Silva, SA, Scazufca, M. & Menezes, PR Demographic impact of depression on functional disability in the elderly: results from the São Paulo Aging & Health Study (SPAH). EUR. Camber. Clin Psychiatry. Neurosci. 263153-158 (2013).
Ly, M. et al. Late-life depression and increased risk of dementia: a longitudinal cohort study. Transl. Psychiatry 11147 (2021).
Wang, YH et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Mol. Psychiatry 251487–1499 (2020).
Machado, MO et al. The association of depression and all-cause and specific mortality: an overview of systematic reviews and meta-analyses. BMC Med. 16112 (2018).
Ferrucci, L. & Fabbri, E. Inflammageing: chronic inflammation in aging, cardiovascular disease and frailty. Nat. Rev. Cardiol. 15505–522 (2018).
McLaughlin, AP et al. The influence of comorbid depression and overweight on peripheral inflammation and cortisol levels. Psychol. Med. 181–8 (2021).
Furman, D. et al. Chronic inflammation in disease etiology throughout life. Nat. Med. 251822–1832 (2019).
Diniz, BS, Iii, CFR, Sibille, E., Bot, M. & Penninx, BWJH Major depression and increased molecular senescence abnormalities in young and middle-aged adults. Transl. Psychiatry 9198 (2019).
Martínez-Cengotitabengoa, M. et al. Peripheral inflammatory parameters in late depression: a systematic review. Int. J.Mol. Science. 172022 (2016).
Diniz, BS et al. Imbalance of oxidative stress markers in late-onset depression. J. Psychiatrist. Res. 10229-33 (2018).
Mohebbi, M. et al. Prevalence of depressive symptoms and its associated factors in healthy community-dwelling older adults living in Australia and the United States. Int. J. Geriatr. Psychiatry 341208-1216 (2019).
Ploubidis, GB, Batty, GD, Patalay, P., Bann, D. & Goodman, A. Association of mental health in early life with biomarkers in midlife and premature mortality: evidence from the UK birth cohort from 1958. JAMA Psychiatry 7838–46 (2021).
Leone, M. et al. Association of childhood depression with later somatic illnesses and premature death. JAMA Psychiatry 78302–310 (2021).
Demnitz, N. et al. Association of depressive symptom trajectories with vascular risk, cognitive function and adverse brain outcomes: the MRI Whitehall II substudy. J. Psychiatrist. Res. 13185–93 (2020).
Kaup, AR et al. Trajectories of depressive symptoms in the elderly and risk of dementia. JAMA Psychiatry 73525–531 (2016).
Almeida, OP, Hankey, GJ, Yeap, BB, Golledge, J. & Flicker, L. Depression as a modifiable factor to decrease the risk of dementia. Transl. Psychiatry 7e1117 (2017).
Quigley, EMM Microbiota-brain-gut axis and neurodegenerative diseases. Fluent. Neurol. Neurosci. Representing. 1794 (2017).
Berk, M. et al. Effects of aspirin on the long-term management of depression in the elderly: a randomized, double-blind, placebo-controlled trial. Mol. Psychiatry 265161–5170 (2021).
Mulugeta, A., Zhou, A., King, C. & Hyppönen, E. Association between major depressive disorder and multiple disease outcomes: a phenomenon-wide Mendelian randomisation study in the UK Biobank. Mol. Psychiatry 251469-1476 (2020).
Ohlsson, L. et al. Leaky gut biomarkers in depression and suicidal behaviors. Acta Psychiatrist. Scan. 139185-193 (2019).
Liśkiewicz, P. et al. Analysis of gut microbiota and markers of gut integrity in hospitalized patients with major depressive disorder. Program. Neuropsychopharmacol. Biol. Psychiatry 10611076 (2021).
Snelson, M. et al. Processed foods promote gut barrier permeability and microvascular disease. Science. Forward. 7eabe4841 (2021).
Burgueño, JF & Abreu, MT Toll-like epithelial receptors and their role in gut homeostasis and disease. Nat. Rev. Gastroenterol. Hepatol. 17263–278 (2020).
McNeil, JJ et al. Effect of aspirin on all-cause mortality in healthy older adults. New Eng. J.Med. 3791519-1528 (2018).
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. JR statistics. Soc. Series B methodology. 57289–300 (1995).
Group, AI Study Design of ASPirin in Reducing Events in the Elderly (ASPREE): A Randomized Controlled Trial. Contemp. Clin. Trials 36555–564 (2013).
McNeil, JJ et al. Baseline characteristics of participants in the ASPREE (ASPirin in Reducing Events in the Elderly) study. J. Gerontol. A Biol. Science. Med. Science. 721586-1593 (2017).
Stocks, NP et al. Quality of life of 19,114 participants in the ASPREE (ASPirin in Reducing Events in the Elderly) study and their association with sociodemographic and modifiable lifestyle risk factors. Qual. Life Res. 28935–946 (2019).
Berk, M. et al. ASPREE-D: aspirin for the prevention of depression in the elderly. Int. Psychogeriatrician. 281741-1748 (2016).
Agustini, B. et al. Patterns of association between depressive symptoms and chronic medical morbidities in the elderly. Jam. Geriatrics. Soc. 681834–1841 (2020).
Gandek, B. et al. Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: results from the IQOLA project. J. Clin. Epidemiol. 511171–1178 (1998).
Chang, K.-F. & Weng, L.-J. Screening for depressive symptoms in the elderly in Taiwan: cut-off point of an abbreviated form of the Center for Epidemiological Studies Depression Scale. Health (Irvine) 5588-594 (2013).
Mohebbi, M. et al. Psychometric properties of an abbreviated form of the Center for Epidemiological Studies Depression Scale (CES-D-10) for screening for depressive symptoms in healthy, community-dwelling older adults. General Hosp. Psychiatry 51118-125 (2018).
Irwin, M., Artin, KH & Oxman, MN Screening for depression in older adults. Camber. Internal Med. 1591701–1704 (1999).
McNeil, JJ et al. Effect of aspirin on cardiovascular events and bleeding in healthy older adults. New Eng. J.Med. 3791509-1518 (2018).
McNeil, JJ et al. Effect of aspirin on disability-free survival in healthy older adults. New Eng. J.Med. 3791499-1508 (2018).
van Buuren, S. & Groothuis-Oudshoorn, K. mouse: multivariate imputation by chained equations in R. J. Stat. Software 451–67 (2011).
Proust-Lima, C., Philipps, V. & Liquet, B. Estimation of extended mixed models using latent classes and latent processes: the lcmm R package. J. Stat. Software. 781–56 (2017).
Berlin, KS, Williams, NA & Parra, GR An introduction to modeling mixtures of latent variables (Part 1): overview and cross-sectional analyzes of latent classes and latent profiles. J. Pediatr. Psychol. 39174-187 (2014).
Myung, IJ Tutorial on Maximum Likelihood Estimation. J.Math. Psychol. 4790-100 (2003).
Hubbard, AE et al. To GEE or not to GEE: comparison of mean and mixed population models to estimate associations between neighborhood risk factors and health. Epidemiology 21467–474 (2010).
Wolfe, R. et al. Aspirin in reducing events in the elderly trial: statistical analysis plan. Int. J.stroke 13335–338 (2018).